Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Obstructive Lung Diseases

  Free Subscription


2 Allergy
3 Ann Allergy Asthma Immunol
1 Clin Exp Allergy
1 Eur Respir J
2 J Allergy Clin Immunol
5 J Asthma
1 J Investig Allergol Clin Immunol
5 Pediatr Allergy Immunol
1 Pediatr Pulmonol
3 Respir Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CAMINATI M, Buhl R, Corren J, Hanania NA, et al
    Tezepelumab in patients with allergic and eosinophilic asthma.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15986.
    PubMed         Abstract available

  2. LEE E, Rhee EH, Yu J, Kim K, et al
    Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID-19 pandemic.
    Allergy. 2023 Dec 23. doi: 10.1111/all.15992.

    Ann Allergy Asthma Immunol

  3. AKEL MJ, Camargo CA Jr, Fujiogi M, Hasegawa K, et al
    Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01514.

  4. PEREZ-DE-LLANO L, Scelo G, Canonica GW, Chen W, et al
    Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01508.
    PubMed         Abstract available

  5. CAMARGO CA JR, Rane PB, Beck AF, Wang Y, et al
    Geographic Variation in Disease Burden Among Patients with Severe Persistent Asthma in the United States.
    Ann Allergy Asthma Immunol. 2023 Dec 21:S1081-1206(23)01501.
    PubMed         Abstract available

    Clin Exp Allergy

  6. VOGELBERG C, Klimek L, Kruppert S, Becker S, et al
    Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
    Clin Exp Allergy. 2023 Dec 26. doi: 10.1111/cea.14444.
    PubMed         Abstract available

    Eur Respir J

  7. WECKMANN M, Reddy KD
    Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow.
    Eur Respir J. 2023;62:2301552.

    J Allergy Clin Immunol

  8. STEMPEL DA, Szefler SJ
    Is the assessment of asthma treatment efficacy sufficiently comprehensive?
    J Allergy Clin Immunol. 2023 Dec 20:S0091-6749(23)02458.
    PubMed         Abstract available

  9. HAN YY, Gutwein A, Apter A, Celedon JC, et al
    Health Literacy and Asthma: An Update.
    J Allergy Clin Immunol. 2023 Dec 20:S0091-6749(23)02459.
    PubMed         Abstract available

    J Asthma

  10. BUENDIA JA, Patino DG, ZuluagaSalazar AF
    Economic Evidence Supports the Cost Savings of Sputum Eosinophil Counts to guide the treatment of pediatrics patients with Persistent Asthma: Implications for Clinical Practice Guidelines in Middle-Income Countries.
    J Asthma. 2023 Dec 25:1-7. doi: 10.1080/02770903.2023.2300085.
    PubMed         Abstract available

  11. MARTINEZ-MORAGON E, Antepara Ercoreca I, Munoz Garcia M, Casas Maldonado F, et al
    Patient-reported outcome measures in severe asthma: an expert consensus.
    J Asthma. 2023 Dec 26:1-13. doi: 10.1080/02770903.2023.2297372.
    PubMed         Abstract available

  12. COLQUE-BAYONA M, Hernandez-Cano N, Tomas-Perez M, Caballero T, et al
    Global Influence of Dupilumab on Quality of Life in a Severe Asthma Patient with T2 Multimorbidities: A Case Report on Atopic Dermatitis, Chronic Rhinosinusitis with Nasal Polyposis, and Eosinophilic Esophagitis.
    J Asthma. 2023 Dec 28:1-11. doi: 10.1080/02770903.2023.2300712.
    PubMed         Abstract available

  13. GONZALEZ-DIAZ SN, Ansotegui IJ, Macouzet-Sanchez C, Acuna-Ortega N, et al
    Doxofylline as a steroid-sparing treatment in Mexican children with asthma.
    J Asthma. 2023 Dec 28:1-10. doi: 10.1080/02770903.2023.2294909.
    PubMed         Abstract available

  14. MOHAMED BME, Laz N, Saeed H, Alghamdi S, et al
    Application of Different Counseling Strategies for Better Adult Asthma Control.
    J Asthma. 2023 Dec 28:1-11. doi: 10.1080/02770903.2023.2300709.
    PubMed         Abstract available

    J Investig Allergol Clin Immunol

  15. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as diagnostic criteria in Asthma-COPD overlap syndrome. Prevalence and characterization of the syndrome in a real-life asthma cohort.
    J Investig Allergol Clin Immunol. 2023 Dec 22:0. doi: 10.18176/jiaci.0966.

    Pediatr Allergy Immunol

  16. CUSTOVIC D, Fontanella S, Custovic A
    Understanding progression from pre-school wheezing to school-age asthma: Can modern data approaches help?
    Pediatr Allergy Immunol. 2023;34:e14062.
    PubMed         Abstract available

  17. KAMGA A, Manca E, Caimmi D, Eigenmann P, et al
    Editorial comment on: "Developing a prediction model of children's asthma risk using population-based family history health records".
    Pediatr Allergy Immunol. 2023;34:e14063.

  18. FARRAIA M, Mendes FC, Sokhatska O, Rama T, et al
    Component-resolved diagnosis in childhood and prediction of asthma in early adolescence: A birth cohort study.
    Pediatr Allergy Immunol. 2023;34:e14056.
    PubMed         Abstract available

  19. DINARDO G, Cafarotti A, Galletta F, Fiocchi A, et al
    Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluation.
    Pediatr Allergy Immunol. 2023;34:e14057.

  20. DONATH H, Klenner H, Hutter M, Meoli A, et al
    Severe bronchial hyperresponsiveness along with house dust mite allergy indicates persistence of asthma in young children.
    Pediatr Allergy Immunol. 2023;34:e14047.
    PubMed         Abstract available

    Pediatr Pulmonol

  21. PRAKASH KJ, Gourishankar A
    Asthma care: The need for evidence-based, equitable, and affordable approaches.
    Pediatr Pulmonol. 2023 Dec 27. doi: 10.1002/ppul.26825.

    Respir Med

  22. WATSON KE, Lee AL, Dwyer TJ, McKeough ZJ, et al
    Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments implemented by allied health professionals and nurses.
    Respir Med. 2023 Dec 21:107503. doi: 10.1016/j.rmed.2023.107503.
    PubMed         Abstract available

  23. VISSER E, Ten Brinke A, Sizoo D, Pepels JJS, et al
    Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review.
    Respir Med. 2023;221:107504.
    PubMed         Abstract available

  24. DE-MIGUEL-DIEZ J, Gutierrez-Albaladejo N, Caballero-Segura FJ, Lopez-de-Andres A, et al
    Trends and sex differences in atrial fibrillation among patients hospitalized due to asthma: Insights from a nationwide population-based discharge database in Spain, 2016-2021.
    Respir Med. 2023;221:107508.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.